TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

CROSSMEDIKA SA

Infectious DiseaseRespiratoryDermatology
Generics

CROSSMEDIKA SA is a generic drug manufacturer focused on Infectious Disease, Respiratory, Dermatology. Key products include MOXIFLOXACIN HYDROCHLORIDE.

2016
Since
5
Drugs
-
Trials
39
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
MOXIFLOXACIN HYDROCHLORIDE 2025-08-28
Labeling
MOXIFLOXACIN HYDROCHLORIDE 2025-08-28
Labeling
MOXIFLOXACIN HYDROCHLORIDE 2025-08-04
MOXIFLOXACIN HYDROCHLORIDE 2025-07-10
Labeling
TRAZODONE HYDROCHLORIDE 2025-06-24
Labeling
TRAZODONE HYDROCHLORIDE 2025-06-24
Labeling
TRAZODONE HYDROCHLORIDE 2025-06-24
Labeling
TRAZODONE HYDROCHLORIDE 2025-06-24
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 25%
1 drugs
Respiratory 25%
1 drugs
Dermatology 25%
1 drugs
Cardiovascular 25%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Respiratory
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Dermatology, Respiratory
B BRAUN specialty
Infectious Disease, Dermatology, Cardiovascular
COSETTE other
Cardiovascular, Dermatology, Infectious Disease